# lisdexamfetamine dimesylate

NDC: 47781-565
Generic name: lisdexamfetamine dimesylate
Labeler / Manufacturer: Alvogen Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20230825

FDA application: ANDA214547

## Active ingredients

- LISDEXAMFETAMINE DIMESYLATE: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"47781-565"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=47781-565
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f2dd6ee-3363-c87c-9693-ed838942556c